Literature DB >> 17666782

First reported case of lysinuric protein intolerance (LPI) in Lithuania, confirmed biochemically and by DNA analysis.

Loreta Cimbalistiene1, Willy Lehnert, Kirsi Huoponen, Vaidutis Kucinskas.   

Abstract

We report on an 18-year-old Lithuanian girl with hepatosplenomegaly noticed at birth, which progressed thereafter. The patient had to wait about 17 years for an accurate diagnosis and appropriate therapy. Lactase deficiency, congenital cataract of the right eye, and osteoporosis were observed. Episodes of drowsiness were caused by intake of high-protein food. Laboratory findings included slight hyperammonaemia, high plasma Citr, Ala, Gly, Glu, Ser levels, as well as citrullinuria, lysinuria, glutaminuria, alaninuria, argininuria, prolinuria, hydroxyprolinuria, ornithinuria, and orotic aciduria. Aversion to high-protein diet strongly suggested a disorder resulting in hyperammonaemia. Citrullinaemia was suspected. Subsequently the diagnosis of LPI was made on the basis of biochemical and clinical features. Molecular genetic testing revealed a mutation in the SLC7A7 gene, confirming the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666782     DOI: 10.1007/BF03195224

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  20 in total

1.  Five novel SLC7A7 variants and y+L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance.

Authors:  Yutaka Shoji; Atsuko Noguchi; Yasuko Shoji; Mika Matsumori; Yuhei Takasago; Masaki Takayanagi; Yoshihiro Yoshida; Kenji Ihara; Toshiro Hara; Shuichi Yamaguchi; Makoto Yoshino; Masayuki Kaji; Shigenori Yamamoto; Akio Nakai; Akio Koizumi; Youichi Hokezu; Keiji Nagamatsu; Hitoshi Mikami; Isao Kitajima; Goro Takada
Journal:  Hum Mutat       Date:  2002-11       Impact factor: 4.878

2.  Basolateral-membrane transport defect for lysine in lysinuric protein intolerance.

Authors:  J Rajantie; O Simell; J Perheentupa
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

3.  Two alternative promoters regulate the expression of lysinuric protein intolerance gene SLC7A7.

Authors:  Kirsi Puomila; Olli Simell; Kirsi Huoponen; Juha Mykkänen
Journal:  Mol Genet Metab       Date:  2006-12-29       Impact factor: 4.797

4.  Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene.

Authors:  Maria Pia Sperandeo; Patrizia Annunziata; Virginia Ammendola; Valentina Fiorito; Antonio Pepe; Maria Virginia Soldovieri; Maurizio Taglialatela; Generoso Andria; Gianfranco Sebastio
Journal:  Hum Mutat       Date:  2005-04       Impact factor: 4.878

5.  Oral administration of epsilon N-acetyllysine and homocitrulline in lysinuric protein intolerance.

Authors:  J Rajantie; O Simell; J Perheentupa
Journal:  J Pediatr       Date:  1983-03       Impact factor: 4.406

6.  Protein intolerance with deficient transport of basic aminoacids. Another inborn error of metabolism.

Authors:  J Perheentupa; J K Visakorpi
Journal:  Lancet       Date:  1965-10-23       Impact factor: 79.321

7.  Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.

Authors:  D Torrents; J Mykkänen; M Pineda; L Feliubadaló; R Estévez; R de Cid; P Sanjurjo; A Zorzano; V Nunes; K Huoponen; A Reinikainen; O Simell; M L Savontaus; P Aula; M Palacín
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

8.  Hyperammonemia in lysinuric protein intolerance.

Authors:  T Kato; N Mizutani; M Ban
Journal:  Pediatrics       Date:  1984-04       Impact factor: 7.124

9.  Lysinuric protein intolerance. Basolateral transport defect in renal tubuli.

Authors:  J Rajantie; O Simell; J Perheentupa
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

10.  Early detection of lung involvement in lysinuric protein intolerance: role of high-resolution computed tomography and radioisotopic methods.

Authors:  F Santamaria; G Parenti; G Guidi; A Rotondo; G Grillo; M R Larocca; L Celentano; P Strisciuglio; G Sebastio; G Andria
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

View more
  6 in total

1.  First report of a molecular prenatal diagnosis in a tunisian family with lysinuric protein intolerance.

Authors:  Nadia Esseghir; Chiraz Souissi Bouchlaka; Sondess Hadj Fredj; Amel Ben Chehida; Hatem Azzouz; Monique Fontaine; Neji Tebib; Marie Françoise Ben Dridi; Gilbert Briand; Taieb Messaoud; Amel Ben Ammar Elgaaied; Naziha Kaabachi
Journal:  JIMD Rep       Date:  2011-06-22

2.  Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat.

Authors:  Mariona Font-Llitjós; Benjamín Rodríguez-Santiago; Meritxell Espino; Ruth Sillué; Sandra Mañas; Laia Gómez; Luis A Pérez-Jurado; Manuel Palacín; Virginia Nunes
Journal:  Eur J Hum Genet       Date:  2008-08-20       Impact factor: 4.246

Review 3.  Food triggers and inherited metabolic disorders: a challenge to the pediatrician.

Authors:  Evelina Maines; Annunziata Di Palma; Alberto Burlina
Journal:  Ital J Pediatr       Date:  2018-01-25       Impact factor: 2.638

4.  Lysinuric protein intolerance in a family of Mexican ancestry with a novel SLC7A7 gene deletion. Case report and review of the literature.

Authors:  David Carpentieri; Margaret F Barnhart; Kyrieckos Aleck; Tamir Miloh; Daphne deMello
Journal:  Mol Genet Metab Rep       Date:  2015-01-10

5.  Effect of Genetic Testing on Diagnosing Gastrointestinal Pediatric Patients with Previously Undiagnosed Diseases.

Authors:  Eyad Altamimi; Mariam Khanfar; Omar Rabab'h; Zain Dardas; Luma Srour; Lina Mustafa; Bilal Azab
Journal:  Appl Clin Genet       Date:  2020-12-16

6.  Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature.

Authors:  Josefina Longeri Contreras; Mabel A Ladino; Katherine Aránguiz; Gonzalo P Mendez; Zeynep Coban-Akdemir; Bo Yuan; Richard A Gibbs; Lindsay C Burrage; James R Lupski; Ivan K Chinn; Tiphanie P Vogel; Jordan S Orange; M Cecilia Poli
Journal:  Front Pediatr       Date:  2021-05-20       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.